Medicare Planning To Pay Too Much For Lab Services? Grassley And GAO Say 'Yes'
Executive Summary
Senate Finance Committee Chairman Chuck Grassley says Medicare would be overpaying for laboratory tests if it goes forward with its planned increases to diagnostic prices on the Medicare Clinical Lab Fee Schedule (CLFS). Industry groups disagree.
You may also be interested in...
Clinical Lab Group Gets Go-Ahead On Medicare Payment Suit
The American Clinical Laboratory Association (ACLA) may proceed with a lawsuit against the US Department of Health and Human Services, an appeals court has ruled. The suit alleges that the agency is setting lab test payment rates unfairly.
Lab Groups Disagree With GAO That Medicare Will Be Overbilled For PAMA Test Payments
A coalition of US laboratories and diagnostic test-makers say it strongly disagrees with GAO’s conclusions that labs will be overbilling Medicare for future payments under the “Protecting Access To Medicare Act of 2014”, and sent a letter to GAO managers last week arguing its case.
Medicare Allows Use Of Hospital Outreach Lab Pay Data; Industry Applauds, But Still Sues
The clinical laboratory industry praised the US Centers for Medicare and Medicaid Services for making changes in its final Clinical Laboratory Fee Schedule rule to allow more data from hospital outreach labs to be considered in setting laboratory test pay rates. But lab advocates are still pursuing a lawsuit and pushing for legislative reforms.